WASHINGTON – COVID-19 vaccines that specifically target the Omicron and other variants are under development, Pfizer Inc’s chief executive said on Wednesday, adding that the company will be able to…
BEIJING – China’s Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the…
(This Feb. 16 story has been corrected to show price to be very similar to high-dose flu vaccine, not COVID vaccine, in paragraph 8) By Francesco Guarascio BRUSSELS – An…